Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane and endocytic machinery represent a complex assembly of lipids and proteins that regulate the interface between a cell and its environment. This system facilitates the internalization of extracellular molecules, plasma membrane proteins, and lipids through various pathways, including clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis (Doherty & McMahon, 2009, Nature Reviews Molecular Cell Biology). Beyond basic nutrient uptake, this machinery is critical for the regulation of cell signaling by controlling the surface expression of receptors and for maintaining cellular homeostasis (Mellman & Yarden, 2013, Nature Reviews Cancer). In clinical contexts, the endocytic pathway is a major route for the entry of pathogens, including SARS-CoV-2 and Influenza, and is frequently dysregulated in cancers to promote growth factor signaling (Cossart & Helenius, 2014, Cold Spring Harbor Perspectives in Biology). While the system as a whole is too broad to be a single drug target, specific components like clathrin, dynamin, and various Rab GTPases are subjects of intense research for therapeutic intervention (Dutta & Donaldson, 2012, Cell). Drugs such as chloroquine and hydroxychloroquine exert their effects by altering the pH of endosomal compartments, thereby inhibiting the processing of internalized materials (Schrezenmeier & Dörner, 2020, Nature Reviews Rheumatology).
Modulation of endosomal pH, inhibition of GTPase activity (e.g., dynamin), and physical disruption of clathrin-mediated vesicle formation (Schrezenmeier & Dörner, 2020, Nature Reviews Rheumatology; Dutta & Donaldson, 2012, Cell).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membranes and endocytic machinery.